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Clinical ResearchErroneous Measurement of the Aortic
Annular Diameter Using 2-Dimensional
Echocardiography Resulting in
Inappropriate CoreValve Size Selection
A Retrospective Comparison With Multislice Computed Tomography
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Montreal, Quebec, Canada; Galway, Ireland; and Munich, GermanyObjectives This study sought to assess the differential adherence to transcatheter heart valve
(THV)-oversizing principles between transesophageal echocardiography (TEE) and multislice computed
tomography (CT) and its impact on the incidence of paravalvular leak (PVL).
Background CT has emerged as an alternative to 2-dimensional TEE for THV sizing.
Methods In our early experience, TEE-derived aortic annular diameters determined THV size selection.
CT datasets originally obtained for vascular screening were retrospectively interrogated to determine
CT-derived annular diameters. Annular dimensions and expected THV oversizing were compared
between TEE and CT. The incidence of PVL was correlated to TEE- and CT-based oversizing calculations.
Results Using TEE-derived annulus measurements, 157 patients underwent CoreValve implantation
(23 mm: n ¼ 66; 29 mm: n ¼ 91). The estimated THV oversizing on the basis of TEE was 20.1  8.2%.
Retrospective CT analysis yielded larger annular diameters than TEE (p < 0.0001). When these CT
diameters were used to recalculate the percentage of oversizing achieved with the TEE-selected
CoreValve, the actual THV oversizing was only 10.4  7.8%. Consequently, CT analysis suggested that
up to 50% of patients received an inappropriate CoreValve size. When CT-based sizing criteria were
satisﬁed, the incidence of PVL was 21% lower than that with echocardiography (14% vs. 35%;
p ¼ 0.003). Adherence to CT-based oversizing was independently associated with a reduced incidence
of PVL (odds ratio 0.36; 95% conﬁdence interval: 0.14 to 0.90; p ¼ 0.029); adherence to TEE-based
sizing was not.
Conclusions Retrospective CT-based annular analysis revealed that CoreValve size selection by TEE
was incorrect in 50% of patients. The percentage of oversizing with CT was one-half of that calculated
with TEE resulting in the majority of patients receiving a THV that was too small. (J Am Coll Cardiol
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and Acronyms
AUC = area under the curve
CI = conﬁdence interval
CT = computed tomography
D = dimensional
OR = odds ratio
PVL = paravalvular leak
ROC = receiver-operating
characteristic




THV = transcatheter heart
valve
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653Appropriate valve sizing is of critical importance to opti-
mize outcomes in patients undergoing transcatheter
aortic valve replacement (TAVR). Oversizing the trans-
catheter heart valve (THV) relative to the aortic annulus
is required to generate interference between the prosthesis
and the annulus and thus to provide adequate anchoring
and sealing. Insufﬁcient THV oversizing (i.e., selecting a
valve that is too small) can be problematic and may result in
intraprocedural valve embolization, or more commonly
paravalvular leak (PVL), an independent predictor of poor
long-term prognosis (1,2). However, excessive THV over-
sizing has been associated with annular rupture (balloon-
expandable TAVR) and/or prosthesis dysfunction (3).
Historically, 2-dimensional (D) echocardiography was
the imaging modality of choice for TAVR sizing. More
recently, multislice computed tomography (CT) has
emerged as an alternative and perhaps superior technique
(4). CT provides a more reliable and detailed anatomical
assessment of the aortic valvular complex and yields larger
aortic annular diameters than echocardiography (5–11).
Consequently, echocardiographic-based TAVR sizing may
be inaccurate and may fail to provide the expected THV
oversizing. Supporting this hypothesis is the observation that
the rates of both PVL and mortality decline with CT-based
sizing (5–11). Although it is axiomatic that the superiority of
CT-based sizing is achieved through more accurate adher-
ence to manufacturer THV-oversizing principles, this
hypothesis has not been corroborated.
We sought to assess the differential adherence to THV-
oversizing principles between 2D-echocardiography and
multislice CT and to further correlate this difference with
rates of PVL in a large series of patients undergoing TAVR.
Methods
Patients. Between January 6, 2009 and June 6, 2010, 165
consecutive high-risk patients with severe aortic stenosis
underwent vascular access screening with CT prior to
TAVR at the German Heart Centre, Munich. Patients with
symptomatic severe aortic stenosis (valve area 1.0 cm2)
were considered candidates for TAVR if surgery was
deemed to be of high or excessive risk. The decision to
proceed with TAVR was discussed by a dedicated Heart
Team. Procedures were performed according to standard
protocol as previously described (12). In this case series, all
patients were treated with the self-expanding CoreValve
system (Medtronic, S.a.r.l, Luxembourg).
TAVR sizing. Early in our experience, CT was routinely
performed to evaluate the iliofemoral vasculature with the
intention of proceeding to transfemoral TAVR. In all
165 cases, TAVR sizing was determined solely using trans-
esophageal echocardiography (TEE)-derived aortic annular
diameters and standard sizing criteria: annulus diameters of
20 to 23 mm and 23 to 27 mm for the 26- and 29-mmCoreValves, respectively. These sizing criteria yield THV
oversizing of 13% to 30% for the 26-mm CoreValve and
7% to 26% for the 29-mm CoreValve (prosthesis diameter
– annulus diameter / annulus diameter  100). Appropriate
valve sizing was deﬁned as adherence to these criteria. The
diameters of the sinuses of Valsalva and the ascending
aorta, the extent of sinotubular and aortic root calciﬁcation,
and the height of the coronary ostia were also considered
when choosing the size of the THV. Only the 26- and
29-mm CoreValves were commercially available during study
enrollment; however, the 31- and 23-mm CoreValves have
more recently received Conformité Européenne–mark ap-
proval. We retrospectively assessed patient eligibility for
these newer prostheses: annular diameter range of 18 to 20mm
and 26 to 29 mm for the 23- and 31-mm CoreValves,
respectively.
Echocardiography. Pre-procedural 2D-TEE was per-
formed in all subjects using a commercially available TEE
transducer and ultrasound system
(X7-2t Live 3D-TEE transducer,
iE33, Philips Medical System,
Andover, Massachusetts) accord-
ing to standard techniques (13).
All images were digitally stored for
off-line analysis. The aortic root
dimensions were measured during
early systole in the 3-chamber
long-axis view at approximately
120 angulation (14). In each pa-
tient, these measurements were
used to calculate the percentage
of THV oversizing and to select
the appropriate valve size for
implantation.
CT acquisition protocol. All ex-
aminations were performed using
a Somatom Deﬁnition Flash CT scanner (Siemens Medical,
Siemens, Munich, Germany). All CT were performed using
the ﬂash technique. Standard technical parameters were used:
gantry rotation time 0.28 ms; axial coverage 0.75 mm
(128  0.6 mm); 80 kV to 120 kV tube voltage according to
body weight; milliampere intensity with Care Dose 4D
modulation; and temporal resolution of 70 ms. Retrospective
electrocardiographic gating was performed. Contrast en-
hancement was achieved with 60 to 100 ml of iomeprol
350mg/ml (Iomeron, Bracco Imaging SpA,Milan, Italy). To
achieve optimal synchronization, a bolus trackingmethod was
used in the ascending aorta. Additional beta-blockade was not
administered. The thickness of reconstructed images was
0.5 mm (increment 0.8 mm).
CT reconstruction and aortic annular measurements.
Among 165 patients with a screening CT, 159 CT datasets
were of sufﬁcient quality for analysis and were retro-
spectively reconstructed using software from 3mensio Valves
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654(version 4.1.sp1, Medical Imaging BV, Bilthoven, the
Netherlands), as previously described (4). The aortic annulus
dimensions were carefully assessed, including the major and
orthogonal minor diameters, the area, and the perimeter.
The CTmean diameter was calculated as the mean of the
major and minor diameters. The CTarea-derived diameter
was calculated using the following equation: 2  O[area
(mm2) / p]. The CTperimeter-derived diameter was deter-
mined as: perimeter (mm) / p. These diameters were
retrospectively calculated for each patient and were applied to
the TEE-based CoreValve size in order to recalculate the CT-
derived THV oversizing and adherence to recommended
oversizing principles. The annular ellipticity index was calcu-
lated as the ratio of the major and minor diameters.
Calciﬁcation of the aortic root speciﬁcally associated with
the valve leaﬂets was evaluated with the automated 3mensio
software. Aortic valvular calciﬁcation was assessed between
the sinotubular junction and 10 mm below the aortic
annulus plane in the left ventricular outﬂow tract; calciﬁca-
tion above and below the aortic leaﬂets was only included
if it was continuous with that on the aortic leaﬂets. We
selected an appropriate threshold value (Hounsﬁeld units)
to highlight and segment only calciﬁed tissue from the
aortic root. This threshold varied among patients due to
differences in image acquisition, and therefore, multiple
values were evaluated for each patient. Appropriate high-
lighting of the calciﬁcation (e.g., excluding opaciﬁed blood
but not obvious calciﬁcation) was visually inspected in each
case to determine the optimal threshold value. For each
cusp, the calciﬁcation volumes were divided into quartiles
and given a corresponding score of 1 to 4. Calciﬁcation
volumes were then summed for each patient and classiﬁed
as trivial (¼ 1), mild (¼ 2), moderate (¼ 3), or severe (¼ 4).
Depth of CoreValve implantation. The depth of CoreValve
implantation was calculated using ﬂuoroscopic imaging. The
height of the CoreValve frame was assessed in the angio-
graphic view with the least foreshortening for calibration so
that the absolute depth could be measured. The distance
from the bottom of each aortic sinus was measured as well as
the total visible length of the device from inﬂow to outﬂow.
The total length of the device was then compared to
the known implanted device height and this ratio was
used to calibrate the depth measurements. Length mea-
surements were recorded in pixels and then converted to
millimeters on the basis of the device length. The right- and
left-sided depths were averaged to provide a single depth
of implant. Suitable angiographic imaging was available in
135 patients.
Endpoints. For the purposes of this study, PVL was the
primary outcome and was deﬁned as post-procedural para-
valvular aortic regurgitation grade 2 or the requirement for
post-implantation balloon dilation despite appropriate
CoreValve position. PVL was assessed using echocardiog-
raphy during the index procedure and prior to discharge, andit was classiﬁed as mild, moderate, or severe according to
the updated Valve Academic Research Consortium criteria
(15). Post-implantation balloon dilation was performed with
a 22- to 25-mm balloon for the 26-mm CoreValve and a
25- to 28-mm balloon for the 29-mm CoreValve. PVL cases
resulting from THV malposition, deﬁned as an implantation
depth >9 mm, were excluded from the analyses. Clinical
outcomes including vascular complications, bleeding, stroke,
myocardial infarction, acute kidney injury, requirement for
new pacemaker, and 30-day and 6-month mortality were
assessed according to the updated Valve Academic Research
Consortium criteria.
Statistical analysis. Continuous variables are presented as
mean  SD, or median and range, according to distribu-
tion. Categorical variables are presented as frequencies and
percentages. Continuous variables were compared with
either the Student t test or Mann-Whitney test. Multiple
comparisons of the aortic annular diameters were analyzed
using analysis of variance with Bonferroni correction or
with the Kruskal-Wallis test. Categorical variables were
compared using the chi-square or Fisher exact test, or
McNemar test for related variables. Univariable and multi-
variable logistic regression analyses were performed to
assess predictors of PVL. All variables that could plausibly
be associated with PVL with a p value of <0.1 in the
univariate analysis were entered into the multivariate model.
Separate models were constructed for each sizing modality
(if p < 0.1) due to multicollinearity of these variables.
Receiver-operating characteristic (ROC) curves were
developed and the areas under the curve (AUC) were
calculated to compare the discriminatory power of TEE and
CT to predict PVL. Comparisons of correlated AUC from
the ROC analysis were compared with the method of
DeLong. The nominal level of signiﬁcance was 5%. Ana-
lyses were performed using SPSS (version 20.0, IBM Corp,
Armonk, New York).
Results
Patients, procedures, and outcomes. Among the 159 pa-
tients with CT datasets of suitable quality, 2 were excluded
due to THV malposition (depth >9 mm). The baseline
characteristics of the remaining 157 patients are presented
in Table 1. Sixty-six patients (42%) received a 26-mm
CoreValve and 91 (58%) received a 29-mm CoreValve.
TEE-derived diameters were signiﬁcantly smaller than
CT-based measurements (p < 0.0001) (Fig. 1A). Compared
with CTarea-, CTmean-, and CTperimeter-derived diameters,
TEE diameters were 1.3 mm (95% conﬁdence interval [CI]:
0.7 to 2.0 mm), 1.5 mm (95% CI: 0.9 to 2.2 mm), and 2.0
mm (95% CI: 1.4 to 2.7 mm) smaller, respectively.
Comparing the CT measurements, there was no signiﬁcant
difference between CTperimeter and CTmean (p ¼ 0.32),
though CTperimeter was marginally larger than CTarea
Figure 1. Annulus Diameter and Percentage Oversizing
(A) Mean aortic annulus diameters measured using transesophageal echo-
cardiography (TEE) and computed tomography (CT). (B) Estimated THV
oversizing according to TEE- and CT-derived annular diameters. Data are
means and 95% conﬁdence intervals. Shaded region represents retrospective
CT analysis. ANOVA ¼ analysis of variance.
Table 1. Study Population: Baseline and Procedural
Characteristics (N ¼ 157)
Baseline characteristics
Age, years 79.7  6.8
Male 56 (35.6)
Body mass index, kg/m2 26.3  4.6
Aortic valve indices
Aortic valve area, mm2 0.7  0.2
Aortic valve peak gradient, mm Hg 76.7  26.8
Aortic valve mean gradient, mm Hg 46.4  17.1
Aortic regurgitation grade 2 21 (13.4)
Left ventricular EF 30% 30 (19.1)
NYHA functional class III/IV 156 (99.4)
Coronary artery disease 86 (54.8)
Prior aortocoronary bypass surgery 17 (10.8)
Peripheral vascular disease 23 (14.7)
Prior stroke 21 (13.4)
Diabetes mellitus 61 (38.8)
Chronic obstructive pulmonary disease 31 (19.8)
Pulmonary hypertension, PAP >60 mm Hg 33 (21.0)
Logistic EuroSCORE 17.8  21.1
STS predicted mortality risk score 5.3  3.4
Procedural characteristics
26-mm CoreValve 66 (42.0)




Direct aortic 4 (2.5)
Values are mean  SD or n (%).
EF ¼ ejection fraction; EuroSCORE ¼ European System for Cardiac Operative Risk Evaluation
score; NYHA ¼ New York Heart Association; PAP ¼ pulmonary artery pressure; STS ¼ Society of
Thoracic Surgeons.
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655(p ¼ 0.05). According to CT, aortic root calciﬁcation was
classiﬁed as trivial in 26%, mild in 25%, moderate in 24%,
and severe in 25% of patients.
Suitability for available CoreValve sizes. We subsequently
analyzed the number of patients whose annular dimen-
sions fell within the range of the manufacturer’s recom-
mended sizing guidelines for the 23-, 26-, 29-, and 31-mm
CoreValves using TEE and CT (Fig. 2). Some patients
were eligible for treatment with 2 THV sizes due to overlap
in the sizing criteria: for example, a 20-mm annulus can be
treated with either a 23- or 26-mm CoreValve. According to
TEE measurements, 95.5% of patients were suitable for
either a 26-mm (35%) or 29-mm (60.5%) CoreValve; 10.8%
were suitable for the 23-mm valve and 10.8% for the 31-mm
CoreValve. In contrast, 18% fewer patients (78.3%) were
suitable for a 26- or 29-mm CoreValve, 11% more (21.7%)
were suitable for a 31-mm device and 8.9% had annuli too
large for currently available valve sizes using CTperimeter.
Furthermore, no patients were eligible for the 23-mm
CoreValve using CTperimeter.Adherence to THV-oversizing criteria. The expected THV
oversizing was calculated by relating the annular diameters
measured with TEE and CT to the implanted CoreValve
size (determined by TEE) (Fig. 1B). With TEE, the
average THV-oversizing was 20.1  8.2%. When CT data
were applied retrospectively, the expected THV oversizing
decreased considerably (p < 0.0001 for trend). Speciﬁcally,
THV oversizing with CTarea, CTmean, and CTperimeter was
13.4  8.2%, 12.6  8%, and 10.4  7.8%, respectively.
This meant that the absolute and relative difference in ex-
pected THV oversizing was 9.7% and 48.3% less using
CTperimeter than when using TEE.
Using the TEE-derived annular measurements, 80.9%
of patients realized the recommended THV oversizing and
hence were deemed to have received the appropriate
CoreValve size (Fig. 3); 19.1% did not achieve the recom-
mended THV oversizing (12.7% excessive and 6.4% insufﬁ-
cient oversizing) and thus received an inappropriate valve size.
Figure 2. Suitability for CoreValve Sizes According to Imaging Modality
The proportion of patients suitable for currently available CoreValve sizes according to aortic annular measurements with TEE and CT. Note, some patients were eligible
for treatment with 2 transcatheter heart valve sizes due to overlap in the sizing criteria. Shaded region represents retrospective CT analysis. Abbreviations as in
Figure 1.
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656When CT data were applied retrospectively to the TEE-
selected CoreValve size, the proportion of patients that
satisﬁed the recommended THV-oversizing criteria
decreased signiﬁcantly (p < 0.0001 for trend). Using CTarea
and CTmean, 60.5% of cases achieved recommended THV-
oversizing. Applying CTperimeter data, only 51% of patients
achieved recommended THV oversizing, and thus 49%Figure 3. Excessive, Insufﬁcient, or Appropriate THV Oversizing
The proportion of patients with excessive, insufﬁcient, or appropriate transcatheter
recommendations on the basis of TEE and CT. Shaded region represents retrospectireceived an inappropriate CoreValve size. With CTperimeter,
30.6% had annuli too large for the available CoreValve
sizes at that time.
THV oversizing and PVL. Following CoreValve implanta-
tion, approximately one-quarter of patients (n ¼ 38)
met the criteria for signiﬁcant PVL (paravalvular aortic
regurgitation grade 2 in 16.1% or need for post-heart valve (THV) oversizing according to the manufacturer’s sizing
ve CT analysis. Abbreviations as in Figure 1.
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657implantation dilation in 8.1%) (Table 2): 14 of 66
(21.2%) 26-mm and 24 of 91 (26.4%) 29-mm CoreValve
(p ¼ 0.57). With TEE, the proportion of patients
with PVL was similar among those that satisﬁed THV-
oversizing criteria and those that did not meet these
criteria (23.6% vs. 26.7%; p ¼ 0.81) (Fig. 4). According
to CTperimeter data, however, the proportion of patients
with PVL was 21% lower in those who satisﬁed THV-
oversizing criteria than those who did not (13.8% vs.
35.1%; p ¼ 0.003).
Using TEE, there was no difference in THV oversizing
between patients with and without PVL (19.0  8.6%
vs. 20.5  8.1%; p ¼ 0.32) (Fig. 5). According to CT
data, there was signiﬁcantly less THV oversizing in those
with PVL than those without PVL (CTarea: 9.0  7.1% vs.
14.9  8.0%, p < 0.0001; CTmean: 9.0  7.2% vs. 13.7 
8.0%, p < 0.001; and CTperimeter: 6.2  7.1% vs. 11.7 
7.5%, p ¼ 0.0001).
Predictors of PVL. In the univariable analysis, several factors
were associated with PVL (Table 3). Interestingly,
increasing aortic annular diameter measured with CT, but
not with TEE, was associated with a higher incidence
of PVL. Similarly, adherence to CT-based rather than
TEE-based THV-oversizing principles was associated with
a reduction in PVL. In the multivariable analysis (Model 1),
adherence to CTperimeter-based TVH oversizing was inde-
pendently associated with a reduction in the incidence
of PVL (odds ratio [OR]: 0.36; 95% CI: 0.14 to 0.90;
p ¼ 0.029), whereas increasing depth of CoreValveTable 2. Procedural and Clinical Outcomes (N ¼ 157)
TAVR performance
Aortic regurgitation grade 2 or post-implantation dilation 38 (17.8)
Aortic valve peak gradient, mm Hg 21.7  7.3
Aortic valve mean gradient, mm Hg 11.3  4.1
Vascular complications
VARC major 14 (8.9)
VARC minor 18 (11.5)
Bleeding
VARC life-threatening 4 (2.6)
VARC major 2 (1.3)
VARC minor 8 (5.1)
Stroke 4 (2.6)
Periprocedural myocardial infarction 1 (0.6)
Acute kidney injury, modiﬁed RIFLE criteria stage 2 or 3* 11 (19.3)
Pacemaker 39 (24.8)
30-day combined safety endpoint 32 (20.4)
30-day mortality 10 (6.4)
VARC cardiovascular 10 (6.4)
VARC noncardiovascular 0 (0.0)
6-month mortality 25 (15.9)
Values are n (%) or mean  SD. *Modiﬁed RIFLE criteria.
RIFLE ¼ Risk, Injury, Failure, Loss, and End-stage Kidney; TAVR ¼ transcatheter aortic valve
replacement; VARC ¼ Valve Academic Research Consortium.implantation (OR: 1.19; 95% CI: 1.04 to 1.35; p ¼ 0.009)
and severe aortic root calciﬁcation (OR: 2.97; 95% CI: 1.2 to
7.38; p ¼ 0.019) were both predictors of increased PVL.
Receiver-operating characteristic curves. ROC curves were
used to compare the precision of TEE and CT to predict
PVL (Fig. 6). TEE appeared to be the least efﬁcacious
imaging modality, with an intercept parallel to the line of
equality (AUC: 0.51). The AUC for CTperimeter (0.65) was
signiﬁcantly greater than that of TEE (p ¼ 0.05), but it
was not signiﬁcantly different from that calculated for CTarea
(0.60) or CTmean (0.59). Adhering to THV-oversizing
criteria with CTperimeter gave a sensitivity, speciﬁcity, positive
predictive value, and negative predictive value of predicting
PVL of 71.1%, 58%, 35.1%, and 86.3%, respectively.
Further analysis of the CTperimeter data with sensitivity-
speciﬁcity curves identiﬁed minimal oversizing thresholds
of 9% for the 26-mm CoreValve and 9.6% for the
29-mm CoreValve that best predicted PVL (Fig. 7). Using
this cut point, the sensitivity, speciﬁcity, positive predictive
value, and negative predictive value for the 26-mm Core-
Valve were 100%, 4.8%, 33%, and 100%. The corresponding
values for the 29-mm CoreValve were 84.2%, 42.4%,
45.7%, and 82.4%. These CTperimeter thresholds predicted
a higher incidence of PVL for both the 26 (33.3% vs.
11.1%; p ¼ 0.037) and 29-mm CoreValves (42.1% vs.
15.1%; p ¼ 0.007).
Discussion
The current study conﬁrms previous observations that CT-
based aortic annular diameters are signiﬁcantly larger than
those obtained by 2D echocardiography. When these CT
diameters were used to recalculate the oversizing relative to
the TEE-selected CoreValve, the actual THV oversizing
was reduced by 48%. Accordingly, the retrospective CT
analysis suggested that up to 50% of patients did not achieve
the manufacturer’s recommended THV-oversizing criteria
and therefore received an inappropriate CoreValve size. CT
data also suggested that one-third of patients had annuli
too large for available CoreValve sizes during the time of
enrollment. Adherence to CT-based but not TEE-based
oversizing was a predictor of reduced PVL. According to
CT, signiﬁcantly lower PVL rates were observed in those
patients who received a correct CoreValve size than in
those who did not. Finally, we identiﬁed a lower limit
threshold for CTperimeter-based THV oversizing associated
with a reduced incidence of PVL: 9% and 9.6% for the
26-mm and 29-mm prostheses, respectively.
Transcatheter heart valve sizing. Pre-procedural anatomical
screening is of considerable importance for TAVR. In
particular, appropriate THV sizing is recognized to be a
key factor for optimizing patient outcomes: PVL is an in-
dependent risk factor for mortality and has been reported
in 9% to 21% of CoreValve and 6% to 13.9% of Edwards
Figure 4. Appropriateness of THV Oversizing and PVL According to Imaging Modality
The proportion of patients with signiﬁcant paravalvular leak (PVL) that achieved (blue) or did not achieve (red) appropriate THV oversizing according to TEE- and
CT-based sizing. Shaded region represents retrospective CT analysis. Abbreviations as in Figures 1 and 3.
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658Sapien (Edwards Lifesciences Inc., Irvine, California)
recipients (1,2,16). Appropriate THV sizing involves
achieving a predeﬁned amount of prosthesis oversizing
relative to the aortic annulus. Previous studies have demon-
strated that failing to achieve a 1:1 ratio of the THV relative
to the aortic annulus (cover index: [TAVR area/annular
area – 1]  100) is associated with PVL (6,8,9,17).
Evidently, accurate measurement of the dimensions of the
aortic annulus is fundamental for accurate THV sizing.
Although there is no consensus as to the gold-standard
technique for measuring the aortic annulus, CT providesFigure 5. THV Oversizing and PVL According to Imaging Modality
Estimated percentage of THV oversizing according to TEE- and CT-based
aortic annular diameters in patients with (diagonal lines) or without (solid)
signiﬁcant paravalvular leak. Shaded region represents retrospective CT
analysis. Abbreviations as in Figures 1, 3, and 4.more accurate annular measurements than TEE does, and
the use of CT for THV sizing has been associated with
improved clinical outcomes (4–10). CT multiplanar refor-
matting allows accurate 3D reconstruction of the aortic
annulus in its true plane. The superiority of this technique
over 2D TEE is explained by the oval shape and variable
orientation of the aortic annulus and the likelihood that
2D echocardiographic imaging will measure a short-axis
tangent across the annulus. Herein, we conﬁrm previous
observations that CT provides larger annular diameters than
TEE does (4–10): CTperimeter-derived diameters were on
average 2.0 mm larger than TEE measurements.
The smaller diameters measured with TEE compared with
CT have a signiﬁcant impact on the amount of THV over-
sizing achieved. In 2007, the oversizing recommendations
suggested by the manufacturer were based on the assumption
that echocardiography was an accurate method of assessing
the annular dimensions. This led us to believe that we were
achieving approximately 20% THV oversizing among Cor-
eValve recipients. When we retrospectively applied CT-
based sizing to the TEE-based valve size, however, we were
surprised to realize that the mean THV oversizing was only
10%. This translates into a 48% relative overestimation of
THV oversizing with TEE versus CT. Obviously, this in-
formation would have had a substantial impact on THV size
selection: up to one-half of all patients were deemed to
have received the incorrect CoreValve size and approximately
30% would have been deemed ineligible for the available
CoreValve prostheses at that time. The results of recent
publications demonstrating enhanced clinical outcomes
with CT-based THV sizing suggest that the initial THV-
oversizing recommendations were appropriate, but the im-
aging modality (2D-echocardiography) was not (5–11).
Table 3. Predictors of PVL
Odds Ratio 95% CI p Value
Univariable model
Age, yrs 0.98 0.93–1.03 0.353
Male 1.44 0.68–3.03 0.343
BMI 0.76 0.13–4.57 0.765
Transfemoral TAVR 1.41 0.49–4.05 0.518
CoreValve size 1.10 0.87–1.41 0.457
Left ventricular EF 1.45 0.93–2.25 0.103
Aortic valve area 0.31 0.05–1.89 0.204
Aortic valve mean gradient 1.03 0.98–1.05 0.320
Logistic EuroSCORE 1.99 0.98–1.04 0.739
STS predicted mortality risk score 1.03 0.92–1.14 0.641
Depth of implant* 1.21 1.07–1.36 0.002
CT ellipticity 0.67 0.26–17.08 0.810
Severe aortic root calciﬁcation* 3.04 1.38–6.68 0.006
Annulus diameter
TEE 1.14 0.94–1.37 0.175
CTarea* 1.32 1.12–1.16 0.001
CTmean* 1.26 1.07–1.48 0.005
CTperimeter* 1.30 1.11–1.53 0.001
Appropriate THV oversizing
TEE 0.85 0.34–2.2 0.726
CTarea* 0.43 0.20–8.9 0.024
CTmean* 0.49 0.23–1.03 0.059
CTperimeter* 0.23 0.10–0.52 <0.0001
Multivariable model 1: CTperimeter
Depth of implant 1.19 1.04–1.35 0.009
Severe aortic root calciﬁcation 2.97 1.20–7.38 0.019
CTperimeter 0.36 0.14–0.90 0.029
Multivariable model 2: CTarea
Depth of implant 1.19 1.05–1.35 0.006
Severe aortic root calciﬁcation 3.31 1.35–8.10 0.009
CTarea 0.60 0.25–1.45 0.258
Multivariable model 3: CTmean
Depth of implant 1.19 1.05–1.35 0.006
Severe aortic root calciﬁcation 3.40 1.39–8.29 0.007
CTmean 0.68 0.28–1.63 0.385
Univariate and multivariate predictors of PVL (grade 2 or post-implantation dilation).
Separate multivariable analysis due to multicollinearity of CT variables. *Variables associated
with PVL in univariate analysis.
BMI ¼ body mass index; CI ¼ conﬁdence interval; CT ¼ computed tomography;
PVL ¼ paravalvular leak; TEE ¼ transesophageal echocardiography; THV ¼ transcatheter heart
valve; other abbreviations as in Tables 1 and 2.
Figure 6. ROC Curves for Predicting PVL According to Adherence to
Oversizing Criteria With TEE and CT
The receiver-operating characteristic (ROC) curves suggest that adherence to
oversizing principles with CTperimeter, CTmean, and CTarea results in more ac-
curate prediction of PVL than using TEE does. TEE ¼ transesophageal echo-
cardiography; other abbreviations as in Figures 1 and 4.
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659In the present study, achieving TEE-based oversizing
recommendations was insensitive for predicting PVL. In
contrast, when CTperimeter data were retrospectively applied,
the proportion of patients with PVL was signiﬁcantly lower
in those that achieved THV-oversizing criteria than in those
that did not (13.8% vs. 35.1%; p ¼ 0.0026). In those with
signiﬁcant PVL, oversizing was 3 more with TEE (19%)
than with CTperimeter (6.2%). This reinforces the message
that TEE led us to select valves that were too small for
patients’ anatomy, especially in those with signiﬁcant PVL.Our ROC analysis further reinforces the hypothesis that
TEE-based sizing was a poor predictor of PVL when
compared with CT measures.
Moderate to severe PVL has been reported in 9% to 21%
of CoreValve and 6% to 13.9% of Edwards Sapien valve
recipients (17). We can speculate that this historical inci-
dence of PVL with TAVR may reﬂect inaccurate TEE-
based sizing in a considerable proportion of patients. Our
data would appear to support previous observations that
CT-sizing can reduce the incidence of signiﬁcant PVL
considerably (23.6% to 13.8%) (8). It is important to note,
however, that appropriate THV sizing is not a panacea
for eliminating PVL. Severe aortic root calciﬁcation and
increasing depth of CoreValve implantation were also in-
dependent predictors of PVL, emphasizing the key role
of pre-procedural CT for optimizing patient selection and
the continued importance of reﬁning procedural techniques.
Which CT diameter to choose? Compared with CTarea and
CTmean, CTperimeter was found to yield larger annular di-
ameters, affect TAVR sizing more frequently, and be a
predictor of PVL in the multivariable analyses. Furthermore,
CTperimeter had the greatest discrimination for PVL in the
ROC analysis. Greater annular dimensions require THV of
larger diameter, which increases the risk of annular rupture
or coronary occlusion. Annular rupture, however, has not
been reported with a self-expanding prosthesis, and coronary
occlusion remains rare, particularly if guidelines regarding
Figure 7. Sensitivity and Speciﬁcity Curves for CTperimeter
The sensitivity and speciﬁcity curves identiﬁed CTperimeter-derived oversizing
thresholds of 9.0% (A) and 9.6% (B) for the 26-mm and 29-mm CoreValves to
be predictive of PVL. Abbreviations as in Figures 1 and 4.
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660sinus of Valsalva width are respected (3,10). Previous in-
vestigators have suggested that CTarea or CTmean are the
most useful determinants of PVL in patients undergoing
balloon-expandable TAVR (6,8,9,11). The mechanistic
differences in the structure and function between the Core-
Valve and the Edwards Sapien valve may explain supremacy
of CTperimeter in this analysis of CoreValve patients. Finally,
CTperimeter-oversizing thresholds of 9% and 9.6% for the 26-
mm and 29-mm CoreValves were predictive of PVL. When
CoreValve oversizing was less than these threshold values,
we observed a 3-fold increase in the rate of PVL.
Study limitations. Post-implantation PVL may be caused
by malposition, underexpansion, or undersizing of the
THV. Differentiating between THV undersizing and
underexpansion remains challenging. Thus, although we
excluded THV-malposition from the analysis, our deﬁni-
tion of PVL included cases where THV post-dilation wasperformed, and thus potentially included patients with
THV-underexpansion rather than THV-undersizing. As
underexpansion is more likely to occur with severe aortic
root calciﬁcation, we performed detailed CT analysis of the
aortic root to identify patients with heavy calciﬁcation.
Signiﬁcantly, after adjusting for both aortic root calciﬁ-
cation and the depth of THV implantation, achieving
CT-based oversizing criteria remained an independent
predictor of reduced PVL. As the CT scans were obtained
early in our TAVI experience, different acquisition pro-
tocols were used. A standardized acquisition protocol
would have further optimized the CT analysis. Fluoro-
scopic assessment of THV malposition was only possible in
135 of 157 patients.
Although the results of this study suggest that CT-based
annular measurements would result in larger valves being
implanted in a large proportion of patients and, compared
with 2D echocardiography, has the potential to reduce PVL,
these strategies were not directly compared in a prospective
manner. Therefore, the retrospective design and observa-
tional nature of the data imply that the conclusions should
be viewed as hypothesis-generating. Furthermore, we did
not use 3D TEE, which correlates more closely with
CT-derived annular measurements, and could mitigate
the inaccuracy associated with 2D TEE (18). Finally, this
consecutive series of patients were treated with the Med-
tronic CoreValve and therefore the ﬁndings should not be
extrapolated to other TAVR systems.
Conclusions
Aortic annular measurements are signiﬁcantly larger when
measured with CT than with TEE. Retrospective applica-
tion of these CT-derived measurements to recalculate the
oversizing of the TEE-selected CoreValve size revealed that
the expected THV oversizing was overestimated 2-fold.
Consequently, the TEE-selected CoreValve size was
incorrect in one-half of all patients. CTperimeter appears to be
the most sensitive CT-based measure for predicting PVL
and is recommended for THV sizing in all patients under-
going CoreValve implantation.
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